Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

OurCrowd eyes $100 million for “pandemic tech” startups

ImpactAlpha, June 4 – Israel-based venture investing platform OurCrowd wants to support emerging health and medical tech innovations, as well as startups addressing social needs, like education access.

“We must plan for future pandemics because this story is just beginning,” wrote OurCrowd’s Jonathan Medved.

As many as 20 of OurCrowd’s portfolio companies are already working on solutions related to the COVID crisis, like vaccine developer MigVaxs.

Last year, OurCrowd launched its first impact fund, linking its cut of returns to impact targets (see, Israel’s OurCrowd is targeting the Sustainable Development Goals – and measuring its own impact).

You might also like...